Strides Pharma Science Limited (STAR) — Board Meeting | 18 August 2026

18 August 2026 · NSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

All resolutions passed at the 35th AGM with near-unanimous shareholder approval

🔄 What Changed

Declaration of final dividend and re-appointment of retiring director

💡 Investor Takeaway

Shareholders approved dividend and director re-appointments, signaling confidence in company stability and governance.

Strides Pharma Science Limited held its 35th Annual General Meeting on August 14, 2026 via video conferencing, where shareholders approved all four key resolutions with near-unanimous support, including adoption of audited financial statements, declaration of final dividend, re-appointment of a retiring director, and payment of commission to non-executive directors. Voting data shows 9,21,72,714 total votes polled, with e-voting participation accounting for the majority, and compliance confirmed with SEBI Listing Regulations and Companies Act requirements.

📄 View Original Announcement (PDF)

📊 Stock Analysis — STAR ✨ Ask AI About This

About Strides Pharma Science Limited (STAR)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹10,612.31 CrP/E: 17.3ROE: 19.7%ROCE: 19.2%Div Yield: 0.43%

View full STAR stock details →

📡 Get AI alerts when STAR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track STAR — Free

💡 Ask AI about this filing

"What is the final dividend amount per share?""How does director re-appointment affect governance?""What were the proxy voting details?"

Ask AI Free →

📊 More STAR filings

Announcement — 24 September 2026Strides Pharma Science Limited has announced that its trading window will close on October 1, 2026, ...
🟡 Sustainability Report — 23 September 2026Strides Pharma Science Limited released its FY26 Sustainability Report, detailing ESG performance ac...
🔴 Announcement — 11 September 2026Strides Pharma Science announced that the USFDA completed a cGMP inspection at its Alathur formulati...
Announcement — 19 August 2026Strides Pharma Science announced that its Bengaluru flagship manufacturing facility received a USFDA...
🔴 Financial Results — 31 July 2026Strides Pharma reported Q1 FY27 revenue of **₹12,654 crores**, up 13% YoY, driven by 17% growth in E...

See all STAR filings →

🔥 Also filed on 18 August 2026

MURUDCERAMurudeshwar Ceramics LimitedAnnual Report LUXINDLux Industries LimitedCorporate Action MMPMMP Industries LimitedCorporate Action VADILALINDVadilal Industries LimitedCorporate Action ONESOURCEOnesource Specialty Pharma LimitedAnnouncement LUXINDLux Industries LimitedAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when STAR files new disclosures

Track STAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.